".................. EF + PA elicits significant effects on different immune cells which is significantly associated with higher OS. Multivariate analysis identified potential target populations for phase III.
Am I the only dumb klutz that thinks this was worthy of a PR to the market?
Hi Ahjay,
Dumb - certainly not, klutz - cant ascertain !
Can only assume our revitalized director LC, left her glasses on the kitchen bench as she scurried off to the office ! Agree good news is hard enough to come by these days without letting any slip through the cracks.
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022
Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022, page-18
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 39.5¢ | $1.515M | 3.783M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 37481 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 0.395 |
3 | 76000 | 0.390 |
4 | 68064 | 0.385 |
10 | 225656 | 0.380 |
1 | 8500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 37481 | 2 |
0.410 | 240538 | 10 |
0.415 | 229395 | 10 |
0.420 | 502644 | 9 |
0.425 | 50700 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |